Literature DB >> 27659347

Comparative analysis of gene expression profiles of OPN signaling pathway in four kinds of liver diseases.

Gaiping Wang1, Shasha Chen, Congcong Zhao, Xiaofang Li, Weiming Zhao, Jing Yang, Cuifang Chang, Cunshuan Xu.   

Abstract

To explore the relevance of OPN signalling pathway to the occurrence and development of nonalcoholic fatty liver disease (NAFLD), liver cirrhosis (LC), hepatic cancer (HC) and acute hepatic failure (AHF) at transcriptional level, Rat Genome 230 2.0 Array was used to detect expression profiles of OPN signalling pathway-related genes in four kinds of liver diseases. The results showed that 23, 33, 59 and 74 genes were significantly changed in the above four kinds of liver diseases, respectively. H-clustering analysis showed that the expression profiles of OPN signalling-related genes were notably different in four kinds of liver diseases. Subsequently, a total of above-mentioned 147 genes were categorized into four clusters by k-means according to the similarity of gene expression, and expression analysis systematic explorer (EASE) functional enrichment analysis revealed that OPN signalling pathway-related genes were involved in cell adhesion and migration, cell proliferation, apoptosis, stress and inflammatory reaction, etc. Finally, ingenuity pathway analysis (IPA) software was used to predict the functions of OPN signalling-related genes, and the results indicated that the activities of ROS production, cell adhesion and migration, cell proliferation were remarkably increased, while that of apoptosis, stress and inflammatory reaction were reduced in four kinds of liver diseases. In summary, the above physiological activities changed more obviously in LC, HC and AHF than in NAFLD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27659347     DOI: 10.1007/s12041-016-0673-7

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  35 in total

1.  Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C.

Authors:  Elena Lima-Cabello; María Victoria García-Mediavilla; María E Miquilena-Colina; Javier Vargas-Castrillón; Tamara Lozano-Rodríguez; Miguel Fernández-Bermejo; José Luis Olcoz; Javier González-Gallego; Carmelo García-Monzón; Sonia Sánchez-Campos
Journal:  Clin Sci (Lond)       Date:  2011-03       Impact factor: 6.124

2.  Expression profiles of the organic acid metabolism-associated genes during rat liver regeneration.

Authors:  G B Guo; C S Xu
Journal:  Amino Acids       Date:  2007-12-19       Impact factor: 3.520

3.  Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.

Authors:  Renee J Phillips; Karla J Helbig; Kylie H Van der Hoek; Devanshi Seth; Michael R Beard
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

4.  Plasma osteopontin in acute liver failure.

Authors:  Praveen Srungaram; Jody A Rule; He Jun Yuan; Andreas Reimold; Benny Dahl; Corron Sanders; William M Lee
Journal:  Cytokine       Date:  2015-03-21       Impact factor: 3.861

5.  Correlation analysis between gene expression profile of rat liver tissues and high-fat emulsion-induced nonalcoholic fatty liver.

Authors:  Cunshuan Xu; Gaiping Wang; Yunpeng Hao; Jia Zhi; Lianxing Zhang; Cuifang Chang
Journal:  Dig Dis Sci       Date:  2011-02-17       Impact factor: 3.199

6.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

Review 7.  Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.

Authors:  Lunxiu Qin
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

8.  Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.

Authors:  Jian Zhao; Li Dong; Bin Lu; Guobin Wu; Dongmei Xu; Jingjing Chen; Kai Li; Xin Tong; Jianxin Dai; Side Yao; Mengchao Wu; Yajun Guo
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

9.  Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.

Authors:  Atul Sahai; Padmini Malladi; Hector Melin-Aldana; Richard M Green; Peter F Whitington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-25       Impact factor: 4.052

10.  Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model.

Authors:  Yue-Fang Liu; Bin-Shan Zha; Hui-Lin Zhang; Xiao-Jing Zhu; Yu-Hua Li; Jin Zhu; Xiao-Hong Guan; Zhen-Qing Feng; Jian-Ping Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-07-29
View more
  3 in total

1.  Circadian modulation of the cardiac proteome underpins differential adaptation to morning and evening exercise training: an LC-MS/MS analysis.

Authors:  Dae Yun Seo; Chang Shin Yoon; Louise Anne Dizon; Sung Ryul Lee; Jae Boum Youm; Won Suk Yang; Hyo-Bum Kwak; Tae Hee Ko; Hyoung Kyu Kim; Jin Han; Robin A McGregor
Journal:  Pflugers Arch       Date:  2020-02-06       Impact factor: 3.657

Review 2.  Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?

Authors:  Tomoya Iida; Kohei Wagatsuma; Daisuke Hirayama; Hiroshi Nakase
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

3.  SPP1 and CXCL9 Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies.

Authors:  Wen Wang; Xiaojing Liu; Peiyao Wei; Feng Ye; Yunru Chen; Lei Shi; Xi Zhang; Jianzhou Li; Shumei Lin; Xueliang Yang
Journal:  Front Med (Lausanne)       Date:  2022-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.